Prof Stefan Müller-Hülsbeck (Diako Hospital Flensburg, DE) discusses IMPERIAL - Eluvia™ versus a polymer-free, paclitaxel-coated stent (Zilver® PTX®) for endovascular femoropopliteal intervention.

Filmed on site by Radcliffe Vascular at LINC 2019.

Editorial Lead: Gary Swanston / David Ramsey 

Videographer: Tom Green

Questions:

1. Why was the IMPERIAL study initiated? (00:09)

2. What was the study design and what did the original data set tell us? (00:35)

3. Can you describe the sub-analysis data presented at LINC 2019? (01:00)

4. How did these devices perform in terms of safety in diabetic patients? (01:45)

5. What conclusions can be made from this data and what questions require further research? (02:51)